$VRMMQ
Vroom, Inc.

2022 Q1 Form 10-K Financial Statement

#000095017022002352 Filed on March 01, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 2020 Q4
Revenue $923.8M $3.184B $405.8M
YoY Change 56.28% 134.53%
Cost Of Revenue $842.1M $2.982B $385.7M
YoY Change 51.75% 131.87%
Gross Profit $81.64M $202.1M $20.10M
YoY Change 125.67% 182.48%
Gross Profit Margin 8.84% 6.35% 4.95%
Selling, General & Admin $188.0M $547.8M $78.10M
YoY Change 72.29% 123.1%
% of Gross Profit 230.27% 271.07% 388.56%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.895M $13.22M $1.390M
YoY Change 171.68% 183.95% -53.82%
% of Gross Profit 9.67% 6.54% 6.92%
Operating Expenses $188.0M $547.8M $79.50M
YoY Change 72.29% 123.1%
Operating Profit -$315.9M -$358.6M -$59.40M
YoY Change 318.25% 100.79%
Interest Expense $9.380M $21.95M -$1.300M
YoY Change 146.07% 127.3%
% of Operating Profit
Other Income/Expense, Net -$12.36M $65.00K $0.00
YoY Change -82486.67% -42.98%
Pretax Income -$333.7M -$370.2M -$60.70M
YoY Change 333.19% 82.6%
Income Tax -$23.24M $754.0K -$100.0K
% Of Pretax Income
Net Earnings -$310.5M -$370.9M -$60.70M
YoY Change 302.21% 82.9%
Net Earnings / Revenue -33.61% -11.65% -14.96%
Basic Earnings Per Share -$2.26 -$2.72
Diluted Earnings Per Share -$2.262M -$2.719M -$459.2K
COMMON SHARES
Basic Shares Outstanding 137.1M 136.4M
Diluted Shares Outstanding 137.3M 136.4M

Balance Sheet

Concept 2022 Q1 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $600.7M $1.132B $1.056B
YoY Change -36.11% 7.21%
Cash & Equivalents $600.7M $1.132B $1.056B
Short-Term Investments
Other Short-Term Assets $265.3M $138.2M $57.40M
YoY Change 417.09% 140.68%
Inventory $741.4M $726.4M $423.6M
Prepaid Expenses
Receivables $103.9M $105.4M $60.58M
Other Receivables $148.2M $0.00 $0.00
Total Short-Term Assets $1.859B $2.102B $1.598B
YoY Change 30.72% 31.57% 243.39%
LONG-TERM ASSETS
Property, Plant & Equipment $44.66M $52.40M $15.09M
YoY Change 25.79% 62.74% 92.8%
Goodwill $0.00 $78.17M
YoY Change -100.0% 0.0%
Intangibles $179.2M $34.00K
YoY Change -94.06%
Long-Term Investments
YoY Change
Other Assets $29.62M $25.03M $15.74M
YoY Change 79.54% 58.44% 30.56%
Total Long-Term Assets $479.3M $264.5M $126.2M
YoY Change 96.28% 109.55% 28.68%
TOTAL ASSETS
Total Short-Term Assets $1.859B $2.102B $1.598B
Total Long-Term Assets $479.3M $264.5M $126.2M
Total Assets $2.339B $2.367B $1.724B
YoY Change 40.32% 37.27% 206.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $52.17M $52.65M $32.93M
YoY Change 21.9% 60.03% 73.41%
Accrued Expenses $139.2M $44.81M $59.41M
YoY Change 357.75% 73.68% 54.33%
Deferred Revenue $73.35M $24.82M
YoY Change 43.29%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $138.9M $512.8M $329.2M
YoY Change -45.08% 55.77%
Total Short-Term Liabilities $1.017B $827.3M $482.7M
YoY Change 123.54% 71.38% 85.78%
LONG-TERM LIABILITIES
Long-Term Debt $687.4M $610.6M $0.00
YoY Change
Other Long-Term Liabilities $16.68M $13.68M $2.151M
YoY Change 4.24% -3.65% -30.0%
Total Long-Term Liabilities $704.1M $624.3M $2.151M
YoY Change 4300.66% 4296.48% -30.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.017B $827.3M $482.7M
Total Long-Term Liabilities $704.1M $624.3M $2.151M
Total Liabilities $1.730B $1.452B $497.0M
YoY Change 267.3% 192.06% 89.02%
SHAREHOLDERS EQUITY
Retained Earnings -$1.459B -$777.9M
YoY Change 35.55%
Common Stock $2.068B $2.005B
YoY Change 25062062.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $608.4M $915.2M $1.227B
YoY Change
Total Liabilities & Shareholders Equity $2.339B $2.367B $1.724B
YoY Change 40.32% 37.27% 206.02%

Cashflow Statement

Concept 2022 Q1 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$310.5M -$370.9M -$60.70M
YoY Change 302.21% 82.9%
Depreciation, Depletion And Amortization $7.895M $13.22M $1.390M
YoY Change 171.68% 183.95% -53.82%
Cash From Operating Activities -$15.08M -$568.7M -$172.4M
YoY Change -151.02% 60.08% 96.47%
INVESTING ACTIVITIES
Capital Expenditures $7.096M $28.41M -$6.270M
YoY Change 119.08% 150.8% 128.83%
Acquisitions $268.2M $75.88M
YoY Change 252.21%
Other Investing Activities -$204.9M -$75.88M $0.00
YoY Change 169.03%
Cash From Investing Activities -$212.0M -$104.3M -$6.270M
YoY Change 167.01% 820.54% 128.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -190.2M 797.7M 79.37M
YoY Change 159.23% -35.51% -61.75%
NET CHANGE
Cash From Operating Activities -15.08M -568.7M -172.4M
Cash From Investing Activities -212.0M -104.3M -6.270M
Cash From Financing Activities -190.2M 797.7M 79.37M
Net Change In Cash -417.2M 124.7M -99.28M
YoY Change 238.67% -85.67% -184.82%
FREE CASH FLOW
Cash From Operating Activities -$15.08M -$568.7M -$172.4M
Capital Expenditures $7.096M $28.41M -$6.270M
Free Cash Flow -$22.17M -$597.1M -$166.1M
YoY Change -184.26% 62.88% 95.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-1112566
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001580864
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-39315
CY2021 dei Entity Registrant Name
EntityRegistrantName
VROOM, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1375 Broadway
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Floor 11
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10018
CY2021 dei City Area Code
CityAreaCode
855
CY2021 dei Local Phone Number
LocalPhoneNumber
524-1300
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2021 dei Trading Symbol
TradingSymbol
VRM
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
4900000000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
137121893
CY2021 dei Auditor Firm
AuditorFirmId
238
CY2021 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2021 dei Auditor Location
AuditorLocation
New York, New York
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1132325000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1056213000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
82450000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
33826000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
8889000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2803000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105433000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60576000
CY2021Q4 us-gaap Inventory Net
InventoryNet
726384000
CY2020Q4 us-gaap Inventory Net
InventoryNet
423647000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
55700000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23617000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
2102292000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1597879000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37042000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15092000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28207000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
34000
CY2021Q4 us-gaap Goodwill
Goodwill
158817000
CY2020Q4 us-gaap Goodwill
Goodwill
78172000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15359000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17137000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
25033000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15742000
CY2021Q4 us-gaap Assets
Assets
2366750000
CY2020Q4 us-gaap Assets
Assets
1724056000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
52651000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
32925000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
121508000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
59405000
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
512801000
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
329231000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
75803000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
24822000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6889000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6052000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
57604000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
30275000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
827256000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
482710000
CY2021Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
610618000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9592000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12093000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4090000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2151000
CY2021Q4 us-gaap Liabilities
Liabilities
1451556000
CY2020Q4 us-gaap Liabilities
Liabilities
496954000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
137092891
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
137092891
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
134043969
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
134043969
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
135000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
132000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2063841000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2004841000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1148782000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-777871000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
915194000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1227102000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2366750000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1724056000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3184255000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357700000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1191821000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2982156000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1286155000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1133962000
CY2021 us-gaap Gross Profit
GrossProfit
202099000
CY2020 us-gaap Gross Profit
GrossProfit
71545000
CY2019 us-gaap Gross Profit
GrossProfit
57859000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
547823000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
245546000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
184988000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12891000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4598000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6019000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-358615000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-178599000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-133148000
CY2021 us-gaap Interest Expense
InterestExpense
21948000
CY2020 us-gaap Interest Expense
InterestExpense
9656000
CY2019 us-gaap Interest Expense
InterestExpense
14596000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
10341000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
5896000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
5607000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
20470000
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
769000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
65000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
114000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-370157000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-202715000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-142810000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
754000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
84000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-573852000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2127000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
901046000
CY2020 vrm Stock Issued During Period Value Conversion Of Redeemable Convertible Preferred Stock Warrant To Common Stock Warrant
StockIssuedDuringPeriodValueConversionOfRedeemableConvertiblePreferredStockWarrantToCommonStockWarrant
21873000
CY2020 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1818000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
3383000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
938000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
357000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
96000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
168000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-370911000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-202799000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-142978000
CY2019 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
132750000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-370911000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-202799000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-275728000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.72
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.76
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-32.04
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
136429791
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
73345569
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8605962
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-296866000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2756000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
466000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1344000
CY2019 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5824000
CY2019 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
132750000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-142978000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13254000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2341000
CY2020 vrm Stock Issued During Period Value Withheld To Satisfy Employee Tax Withholding Obligations
StockIssuedDuringPeriodValueWithheldToSatisfyEmployeeTaxWithholdingObligations
2915000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-202799000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1227102000
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
38811000
CY2021 vrm Adjustments To Additional Paid In Capital Fair Value Of Unvested Stock Options Assumed For Acquisition
AdjustmentsToAdditionalPaidInCapitalFairValueOfUnvestedStockOptionsAssumedForAcquisition
1017000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13409000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5766000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-370911000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
915194000
CY2021 us-gaap Profit Loss
ProfitLoss
-370911000
CY2020 us-gaap Profit Loss
ProfitLoss
-202799000
CY2019 us-gaap Profit Loss
ProfitLoss
-142978000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13215000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4654000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6157000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2872000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
13409000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
13254000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
2756000
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
9471000
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
6588000
CY2019 us-gaap Inventory Write Down
InventoryWriteDown
2682000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
20470000
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
769000
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-9619000
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2375000
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2609000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
53206000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
32068000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18430000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
312208000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
224489000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
92877000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
32452000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9117000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3935000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
9172000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4556000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3487000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
19321000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
14066000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4035000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
61170000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
28431000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10131000
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
50943000
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
7499000
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
10902000
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
29241000
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
19500000
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5673000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-568688000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-355254000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-215636000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28413000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11329000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3528000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
75875000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-104288000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11329000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3528000
CY2019 vrm Repayments Of Long Term Debt And Debt Extinguishment Costs
RepaymentsOfLongTermDebtAndDebtExtinguishmentCosts
25685000
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
2713350000
CY2020 vrm Issuance Of Common Stock As Upfront Payment To Nonemployee
IssuanceOfCommonStockAsUpfrontPaymentToNonemployee
2127000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
760000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
97000
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
200000
CY2020 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1242736000
CY2019 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
992179000
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
2529780000
CY2020 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1086966000
CY2019 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
914200000
CY2021 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
625000000
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
16129000
CY2020 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
21694000
CY2019 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
227502000
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1818000
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5824000
CY2020 vrm Common Stock Shares Withheld To Satisfy Employee Tax Withholding Obligations
CommonStockSharesWithheldToSatisfyEmployeeTaxWithholdingObligations
2915000
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
504024000
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
6791000
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
723000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
569471000
CY2020 vrm Payments Of Costs Related To Follow On Public Offering
PaymentsOfCostsRelatedToFollowOnPublicOffering
1519000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5766000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2341000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1810000
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-495000
CY2020 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3222000
CY2019 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
183000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
797712000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1237035000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
275242000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
124736000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
870452000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
56078000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1090039000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
219587000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
163509000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1214775000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1090039000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
219587000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
15964000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
8540000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
12607000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
403000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
163000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
157000
CY2021 vrm Issuance Of Common Stock For Acquisition Of Business
IssuanceOfCommonStockForAcquisitionOfBusiness
38811000
CY2021 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
1017000
CY2019 vrm Accretion Of Redeemable Convertible Preferred Stock
AccretionOfRedeemableConvertiblePreferredStock
132750000
CY2019 vrm Equity Issuance Costs Included In Accrued Liabilities
EquityIssuanceCostsIncludedInAccruedLiabilities
5020000
CY2020 vrm Conversion Of Redeemable Convertible Preferred Stock Warrant To Common Stock Warrant
ConversionOfRedeemableConvertiblePreferredStockWarrantToCommonStockWarrant
21873000
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2020Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
54.50
CY2020Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
2-for-1
CY2020Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
CY2020Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10800000
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
569500000
CY2020Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1500000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;font-style:italic;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;"> </span></p><p style="text-indent:6.773%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue, and expenses and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to income taxes, the realizability of inventory, stock-based compensation, contingencies, revenue-related reserves, fair value measurements, goodwill, and useful lives of property and equipment and intangible assets. The Company bases its estimates on historical experience, market conditions, and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </span></p><p style="text-indent:6.773%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;"> </span></p><p style="text-indent:6.773%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Due to the evolving and uncertain nature of COVID-19, it is reasonably possible that it could materially impact the Company’s estimates, particularly those noted above that require consideration of forecasted financial information, in the near to medium term. The ultimate impact will depend on numerous evolving factors that the Company may not be able to accurately predict, including the duration and extent of the pandemic, the impact of federal, state, local and foreign governmental actions, consumer behavior in response to the pandemic and other economic and operational conditions the Company may face.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </span></p>
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2021 us-gaap Number Of Reporting Units
NumberOfReportingUnits
3
CY2021Q4 us-gaap Goodwill
Goodwill
158800000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;font-style:italic;">Concentration of Credit Risk and Significant Customers</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;font-style:italic;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;"> </span></p><p style="text-indent:6.773%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">The Company’s principal financial instruments subject to potential concentration of credit risk are cash and cash equivalents and accounts receivable, which are unsecured. The Company’s cash balances are maintained at various large, reputable financial institutions. Deposits held with financial institutions may at times exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and, therefore, management believes they bear minimal risk. The Company’s cash equivalents primarily consist of money market funds that hold investments in highly liquid U.S. treasury securities and commercial paper investments. Concentration of credit risk with respect to accounts receivable is generally mitigated by a large customer base.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </span></p><p style="text-indent:6.773%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">For the years ended December 31, 2021, 2020, and 2019, no customer represented 10% or more of the Company’s revenues and no customer represented more than 10% of the Company’s accounts receivable as of December 31, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">.</span>
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
569500000
CY2020Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1500000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
18400000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17400000
CY2021Q4 vrm Reserve For Chargebacks
ReserveForChargebacks
9600000
CY2020Q4 vrm Reserve For Chargebacks
ReserveForChargebacks
3800000
CY2021Q4 vrm Cumulative Profit Sharing Payment Recognized
CumulativeProfitSharingPaymentRecognized
17900000
CY2020Q4 vrm Cumulative Profit Sharing Payment Recognized
CumulativeProfitSharingPaymentRecognized
11500000
CY2021 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6385000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28207000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
292000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
258000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
34000
CY2021Q4 vrm Vehicles
Vehicles
724542000
CY2020Q4 vrm Vehicles
Vehicles
421458000
CY2021Q4 vrm Parts And Accessories
PartsAndAccessories
1842000
CY2020Q4 vrm Parts And Accessories
PartsAndAccessories
2189000
CY2021Q4 us-gaap Inventory Net
InventoryNet
726384000
CY2020Q4 us-gaap Inventory Net
InventoryNet
423647000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
22400000
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
12900000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57460000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28426000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20418000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13334000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37042000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15092000
CY2021 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
300000
CY2020 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
100000
CY2019 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
100000
CY2019Q4 us-gaap Goodwill
Goodwill
78172000
CY2020 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
0
CY2020Q4 us-gaap Goodwill
Goodwill
78172000
CY2020Q4 us-gaap Goodwill
Goodwill
78172000
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
80645000
CY2021Q4 us-gaap Goodwill
Goodwill
158817000
CY2021Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34592000
CY2020Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6100000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3400000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
6220000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
6215000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
6215000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
6215000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
1172000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
2170000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28207000
CY2021Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
17546000
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
9106000
CY2021Q4 vrm Accrued Vehicle Related Expenses Current
AccruedVehicleRelatedExpensesCurrent
36459000
CY2020Q4 vrm Accrued Vehicle Related Expenses Current
AccruedVehicleRelatedExpensesCurrent
13062000
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
39163000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
15443000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16150000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5749000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4225000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4890000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7965000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11155000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
121508000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
59405000
CY2021Q4 vrm Vehicle Payable Current
VehiclePayableCurrent
30647000
CY2020Q4 vrm Vehicle Payable Current
VehiclePayableCurrent
25086000
CY2021Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
26522000
CY2020Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
5058000
CY2021Q4 vrm Other Current
OtherCurrent
435000
CY2020Q4 vrm Other Current
OtherCurrent
131000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
57604000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
30275000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2021Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.034
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2020Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.034
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
6919000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
5503000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1660000
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
350000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
2921000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
1915000
CY2021 us-gaap Sublease Income
SubleaseIncome
196000
CY2020 us-gaap Sublease Income
SubleaseIncome
445000
CY2021 us-gaap Lease Cost
LeaseCost
11304000
CY2020 us-gaap Lease Cost
LeaseCost
7323000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
6806000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
5524000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1599000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4600000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4076542
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.39
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M26D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3449606
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.83
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y8M26D
CY2019 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
7200000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2964534
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7294000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5404000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3505000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1034000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
12000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
17249000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
768000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
16481000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6889000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9592000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
16481000
CY2020Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
85533394
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On June 11, 2020, the Company amended its certificate of incorporation to effect a 2-for-1 forward stock split of shares of the Company’s outstanding common stock, such that each share of common stock, $0.001 par value became two shares of common stock, $0.001 par value per share.
CY2020Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5617568
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.35
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M29D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
72578
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.97
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1409004
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.09
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
204600
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.73
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
4.04
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y9M21D
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
3560000
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
3943000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
48200000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
26100000
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
20000000.0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2235442
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.46
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
794833
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
34.65
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
573474
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
12.53
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
186988
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
20.24
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2269813
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
24.69
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2021Q4 vrm Segment Assets
SegmentAssets
0
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3184255000
CY2021 us-gaap Gross Profit
GrossProfit
202099000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357700000
CY2020 us-gaap Gross Profit
GrossProfit
71545000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1191821000
CY2019 us-gaap Gross Profit
GrossProfit
57859000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3184255000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357700000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1191821000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
547823000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
245546000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
184988000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12891000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4598000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6019000
CY2021 us-gaap Interest Expense
InterestExpense
21948000
CY2020 us-gaap Interest Expense
InterestExpense
9656000
CY2019 us-gaap Interest Expense
InterestExpense
14596000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
10341000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
5896000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
5607000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
20470000
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
769000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
65000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
114000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
96000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-370157000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-202715000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-142810000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-370640000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-202715000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-142810000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
483000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-370157000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-202715000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-142810000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
679000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
84000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
168000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
75000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
754000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
84000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
168000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0020
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
754000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
84000
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-8251000
CY2021Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
12278000
CY2020Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
12409000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
3617000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
3119000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
168000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
75000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1456000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4197000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
11441000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
6793000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0004
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0012
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-77733000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-42570000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-29990000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-5417000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1096000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-26000
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
0
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
0
CY2021 vrm Income Tax Rate Reconciliation Permanent Differences
IncomeTaxRateReconciliationPermanentDifferences
-4800000
CY2020 vrm Income Tax Rate Reconciliation Permanent Differences
IncomeTaxRateReconciliationPermanentDifferences
1264000
CY2019 vrm Income Tax Rate Reconciliation Permanent Differences
IncomeTaxRateReconciliationPermanentDifferences
772000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
94158000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
46901000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
30051000
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-2594000
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-94000
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
431000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
754000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
84000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
168000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
216000000.0
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
121900000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
203170000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
102252000
CY2021Q4 vrm Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
3821000
CY2020Q4 vrm Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
4175000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
2592000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
1809000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1905000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
836000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
227458000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
126056000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
216017000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
121859000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
11441000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
225000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1088000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
29000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
4197000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-370911000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-202799000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-142978000
CY2019 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
132750000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-370911000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-202799000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-275728000
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
136429791
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
73345569
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8605962
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.72
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.76
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-32.04
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17088414
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7485228
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
93497146

Files In Submission

Name View Source Status
0000950170-22-002352-index-headers.html Edgar Link pending
0000950170-22-002352-index.html Edgar Link pending
0000950170-22-002352.txt Edgar Link pending
0000950170-22-002352-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img172505048_0.jpg Edgar Link pending
img172505048_1.jpg Edgar Link pending
img172505048_2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrm-20211231.htm Edgar Link pending
vrm-20211231.xsd Edgar Link pending
vrm-20211231_cal.xml Edgar Link unprocessable
vrm-20211231_def.xml Edgar Link unprocessable
vrm-20211231_htm.xml Edgar Link completed
vrm-20211231_lab.xml Edgar Link unprocessable
vrm-20211231_pre.xml Edgar Link unprocessable
vrm-ex10_25.htm Edgar Link pending
vrm-ex23_1.htm Edgar Link pending
vrm-ex31_1.htm Edgar Link pending
vrm-ex31_2.htm Edgar Link pending
vrm-ex32_1.htm Edgar Link pending
vrm-ex32_2.htm Edgar Link pending